Business Standard

Strand Life Sciences' liquid biopsy test to help early detection of cancer

It has worked closely with Mazumdar Shaw Center for Translational Research to develop Strand LB test

Blood Test
Premium

BS B2B Bureau Bengaluru
The Bengaluru-based Strand Life Sciences’ new liquid biopsy (LB) test portfolio, Strand LB, will provide highly sensitive detection of tumour traces from a simple blood draw. This tool, launched last week, can provide early and precise indication of tumour presence, cancer recurrence, and response to therapy compared to any other method used in the medical industry.

According to Indian Council of Medical Research (ICMR), India is projected to have 17.3 lakhs new cases of cancer reported in 2020 and over 8.8 lakhs patients are expected to die from the disease. To counter this large burden and rapid increase in incidence and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in